OriGene Technologies Revenue and Competitors

Location

$69.4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • OriGene Technologies's estimated annual revenue is currently $19.8M per year.(i)
  • OriGene Technologies received $0.2M in venture funding in March 2014.
  • OriGene Technologies's estimated revenue per employee is $155,000
  • OriGene Technologies's total funding is $69.4M.

Employee Data

  • OriGene Technologies has 128 Employees.(i)
  • OriGene Technologies grew their employee count by 0% last year.

OriGene Technologies's People

NameTitleEmail/Phone
1
CEO and CFOReveal Email/Phone
2
CEOReveal Email/Phone
3
Sr. VP and General Manager Research Reagent and eCommerceReveal Email/Phone
4
VP antibody developmentReveal Email/Phone
5
V.P. Corporate DevelopmentReveal Email/Phone
6
VP antibody developmentReveal Email/Phone
7
Head Human ResourcesReveal Email/Phone
8
Director, Protein Department (Wuxi, China)Reveal Email/Phone
9
Director InnovationReveal Email/Phone
10
Director OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M2-60%N/AN/A
#2
$2.9M38-31%$17.5MN/A
#3
$2.9M38-33%$10.5MN/A
#4
$19.8M1280%$69.4MN/A
#5
$9.6M62-15%N/AN/A
#6
$1.4M90%N/AN/A
#7
$2.5M160%N/AN/A
#8
$7.4M480%N/AN/A
#9
$0.2M1-83%N/AN/A
#10
$1.7M1122%N/AN/A
Add Company

What Is OriGene Technologies?

OriGene Technologies was founded as a research tool company focused on the creation of the largest commercial collection of full-length human cDNAs in a standard expression vector. The availability of the complete human genome sequence and the subsequent development of genome-based tools have enabled the identification of relevant drug targets through system biology approaches. OriGene's vision is to prepare comprehensive, genome wide research tools and technology platforms to enable scientists to study complete biological pathways, thus enabling a better understanding of disease mechanisms including cancer and stem cell research. OriGene Technologies uses high-throughput, genome wide approach to develop products for pharmaceutical, biotechnology, and academic research. Our flagship product is the cDNA clone collection, a searchable gene bank of over 30,000 human full-length TrueClone cDNA collection and over 25,000 TrueORF cDNA clones. From our TrueORF cDNA clones, we have developed the largest offering of full length human proteins expressed in mammalian cells, ideal for functional studies. In 2010, OriGene initiated the TrueMAB project to develop mouse monoclonal antibodies against protein antigens with the goal to develop protein assays for every human protein. In addition, OriGene offers unique gene expression products such as TissueScan cancer tissue qPCR arrays and tissue biorepository for biomarker discovery and validation OriGene is committed to its mission to be Your Gene Company, in supplying everything a researcher needs for gene based research.

keywords:Biotechnology,E-Commerce,Healthcare,Software Development

$69.4M

Total Funding

128

Number of Employees

$19.8M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

OriGene Technologies News

2022-04-19 - CRISPR and Cas Genes Market Size, Scope And Forecast ...

OriGene Technologies Thermo Fisher Scientific, Takara Bio Inc., Horizon Discovery Ltd., Addgene, Merck KGaA, Caribou Biosciences CRISPR...

2022-04-19 - CRISPR Technology Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The global CRISPR technology market is estimated to be USD 2,251. ... DNA Technologies (IDT)), Merck KGaA, New England Biolabs, Origene...

2022-04-17 - CRISPR and Cas Genes Market Size And Forecast | OriGene ...

OriGene Technologies Thermo Fisher Scientific, Takara Bio Inc., Horizon Discovery Ltd., Addgene, Merck KGaA, Caribou Biosciences CRISPR...

2015-10-28 - OriGene Technologies Acquires Acris Antibodies

OriGene Technologies, Inc., a Rockville, MD-based developer of genome wide products for research and diagnostic applications, acquired Acris Antibodies GmbH, a Herford, Germany and San Diego, CA-based provider of antibodies and other life science related products. The amount of the deal was not ...

2015-07-07 - OriGene Technologies Receives Investment

OriGene Technologies, a Rockville, MD-based life science company producing biotechnology products for the research and medical markets, recently received an investment of undisclosed amount. Backers included Cathay Capital Private Equity, which made the investment through the Sino French Fund f ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27.7M1327%N/A
#2
$19.1M1327%N/A
#3
$23.8M13220%N/A
#4
$19.4M1342%N/A
#5
$24.1M1341%N/A

OriGene Technologies Funding

DateAmountRoundLead InvestorsReference
2004-04-21$0.1MUndisclosedASM ResourcesArticle
2004-05-11$2.3MAEmerging Technology PartnersArticle
2010-03-18$16.0MBDG-Accel, SBI & TH Venture Capital EnterArticle
2013-03-22$21.3MCQiming Venture PartnersArticle
2014-03-12$0.2MUndisclosedArticle